Skip to content

ARIAD PHARMACEUTICALS INC

Delisted

CIK 884731fmd_1J0KAWD7ZQQNC6NKNB2HANRHJGManufacturing · Biological Products, (No Diagnostic Substances)Template: Standard

Coverage: Jan 01, 2009 to Sep 30, 2016, 27 periods

Latest annual · FY2015

Millions
Total revenues
119
Gross profit
117
Operating income
(217)
Net income
(231)
Free cash flow
(176)

Latest quarter · Q3 FY2016

Millions
Total revenues
46
Gross profit
45
Operating income
(25)
Net income
(28)
Free cash flow
(32)
Open Financials

Key stats

Open Analysis

Compound annual growth

Revenue, 3 yearsFY2012 to FY2015
+497.1%
Revenue, 5 yearsFY2010 to FY2015
-7.9%
Net income, 5 yearsFY2010 to FY2015
n/m

ARIAD PHARMACEUTICALS INC financials: quick answers

Annual figures as filed with the SEC. Each number links to the filing it came from and to its proof.

MetricFY2015FY2014ChangeSource
Revenue$118.8 million$105.4 million+12.7%10-K 2016-02-29 · proof
Gross profit$116.7 million$100.2 million+16.5%10-K 2016-02-29 · proof
Operating income-$217.3 million-$160.2 million10-K 2016-02-29 · proof
Net income-$231.2 million-$162.6 million10-K 2016-02-29 · proof
Cash from operating activities-$159.2 million-$57.8 million10-K 2016-02-29 · proof
Free cash flow-$176.5 million-$60.6 million10-K 2016-02-29 · proof
Total assets$546.7 million$603.1 million-9.4%10-K 2016-02-29 · proof
Total liabilities$649.8 million$522.3 million+24.4%10-K 2016-02-29 · proof
Cash and cash equivalents$230.9 million$352.7 million-34.5%10-K 2016-02-29 · proof
Total debt$443.1 million$352.2 million+25.8%10-Q 2016-11-08 · proof
What was ARIAD PHARMACEUTICALS INC's revenue in fiscal 2015?
ARIAD PHARMACEUTICALS INC reported revenue of $118.8 million for fiscal 2015 (the year ended Dec 31, 2015), against $105.4 million the year before (+12.7%). Source: the 10-K filed with the SEC on Feb 29, 2016. SEC
What was ARIAD PHARMACEUTICALS INC's gross profit in fiscal 2015?
ARIAD PHARMACEUTICALS INC reported gross profit of $116.7 million for fiscal 2015 (the year ended Dec 31, 2015), against $100.2 million the year before (+16.5%). Source: the 10-K filed with the SEC on Feb 29, 2016. SEC
What was ARIAD PHARMACEUTICALS INC's operating income in fiscal 2015?
ARIAD PHARMACEUTICALS INC reported operating income of -$217.3 million for fiscal 2015 (the year ended Dec 31, 2015), against -$160.2 million the year before. Source: the 10-K filed with the SEC on Feb 29, 2016. SEC
What was ARIAD PHARMACEUTICALS INC's net income in fiscal 2015?
ARIAD PHARMACEUTICALS INC reported net income of -$231.2 million for fiscal 2015 (the year ended Dec 31, 2015), against -$162.6 million the year before. Source: the 10-K filed with the SEC on Feb 29, 2016. SEC
What was ARIAD PHARMACEUTICALS INC's cash from operating activities in fiscal 2015?
ARIAD PHARMACEUTICALS INC reported cash from operating activities of -$159.2 million for fiscal 2015 (the year ended Dec 31, 2015), against -$57.8 million the year before. Source: the 10-K filed with the SEC on Feb 29, 2016. SEC
What was ARIAD PHARMACEUTICALS INC's free cash flow in fiscal 2015?
ARIAD PHARMACEUTICALS INC reported free cash flow of -$176.5 million for fiscal 2015 (the year ended Dec 31, 2015), against -$60.6 million the year before. Source: the 10-K filed with the SEC on Feb 29, 2016. SEC
What are ARIAD PHARMACEUTICALS INC's total assets?
As of Dec 31, 2015, ARIAD PHARMACEUTICALS INC reported total assets of $546.7 million, against $603.1 million a year earlier (-9.4%). Source: the 10-K filed with the SEC on Feb 29, 2016. SEC
What are ARIAD PHARMACEUTICALS INC's total liabilities?
As of Dec 31, 2015, ARIAD PHARMACEUTICALS INC reported total liabilities of $649.8 million, against $522.3 million a year earlier (+24.4%). Source: the 10-K filed with the SEC on Feb 29, 2016. SEC
What are ARIAD PHARMACEUTICALS INC's cash and cash equivalents?
As of Dec 31, 2015, ARIAD PHARMACEUTICALS INC reported cash and cash equivalents of $230.9 million, against $352.7 million a year earlier (-34.5%). Source: the 10-K filed with the SEC on Feb 29, 2016. SEC
What is ARIAD PHARMACEUTICALS INC's total debt?
As of Dec 31, 2015, ARIAD PHARMACEUTICALS INC reported total debt of $443.1 million, against $352.2 million a year earlier (+25.8%). Source: the 10-Q filed with the SEC on Nov 8, 2016. SEC

Read from the FinancialMD API on Nov 14, 2026. Values change only when a new filing is made; see the Financials tab for every period and as-of replay.

The same numbers for an agent, with proof on every value:

curl "https://api.financial.md/v1/company/financials/income_statement/standardized?company=cik:884731&period_type=annual&limit=5"

Information only, not investment advice.